Conversion From Fast Acting Oral Opioids to Abstral®
This study has suspended participant recruitment.
(Recruitment difficulties)
Sponsor:
Orexo AB
Information provided by (Responsible Party):
Orexo AB
ClinicalTrials.gov Identifier:
NCT01315886
First received: March 14, 2011
Last updated: June 19, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has suspended participant recruitment. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Primary Completion Date: | December 2011 (Final data collection date for primary outcome measure) |